Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0FI1L
|
|||
| Drug Name |
CAD-1883
|
|||
| Indication | Ataxic disorder [ICD-11: 8A03] | Phase 1/2 | [1] | |
| Company |
Cadent Therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Calcium-activated potassium channel KCa2 (KCNN) | Target Info | Activator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.